Department of Ophthalmology, Marmara University School of Medicine, Istanbul, Turkey
Accepted for publication February 4, 2023.
The authors have no financial or conflicts of interest to disclose.
The preliminary findings of this study were presented as an oral presentation at the 40th Congress of the European Society of Ophthalmic Plastic and Reconstructive Surgery on September 16, 2022.
The Institutional Review Board of Marmara University School of Medicine approved the study protocol with the 09.2022.102 protocol number. The procedures used in this study adhered to the tenets of the Declaration of Helsinki.
This study was retrospectively registered at ClinicalTrials.gov (NCT05528016—September 01, 2022).
The data supporting the study findings are available from the corresponding author upon request.
All authors contributed to the study’s conception and design. B.Ş. and V.D. performed material preparation and data collection. V.D., M.O.S., and S.A.T. performed analysis and interpretation of data. V.D. wrote the first draft of the manuscript and all authors commented on previous versions. All authors read and approved the final manuscript.
B.Ş. is deceased (August 13, 2022).
Informed consent was obtained from all participants included in the study. In addition, patients signed informed consent regarding publishing their data and photographs.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (www.op-rs.com).
Address correspondence and reprint requests to Volkan Dericioğlu, M.D., F.E.B. Opht., Marmara Üniversitesi Pendik Eğitim Araştırma Hastanesi, Göz Hastalıkları Anabilim Dalı, Fevzi Çakmak Mah., Muhsin Yazıcıoğlu Cad., No: 10, Üst Kaynarca/Pendik/İstanbul 34890, Turkey. E-mail: [email protected]
